Literature DB >> 18223157

Intrinsic sensor of oncogenic transformation induces a signal for innate immunosurveillance.

Arun M Unni1, Tanya Bondar, Ruslan Medzhitov.   

Abstract

Multiple cell-autonomous mechanisms exist in complex metazoans to resist oncogenic transformation, including a variety of tumor- suppressor pathways that control cell proliferation and apoptosis. In vertebrates, additional mechanisms of tumor resistance could potentially rely on cancer cell elimination by specialized cytotoxic leukocytes, such as natural killer (NK) cells. Such mechanisms would require that cancer cells be reliably distinguished from normal cells. The ligands for NKG2D, an activating NK cell receptor, are expressed on many tumor cell lines and at least some primary human tumors. However, it is unknown whether their expression is induced as a direct result of oncogenic transformation in vivo. We provide evidence that NKG2D ligands are induced on spontaneously arising tumors in a murine model of lymphomagenesis and that c-Myc is involved in their regulation. Expression of NKG2D ligands is induced at an early, distinct stage of tumorigenesis upon acquisition of genetic lesions unique to cancer cells, potentially defining a critical step in carcinogenesis. This finding suggests that the regulation of NKG2D ligands depends on a mechanism for intrinsic sensing of oncogenic transformation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18223157      PMCID: PMC2234205          DOI: 10.1073/pnas.0701675105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  Decoding the patterns of self and nonself by the innate immune system.

Authors:  Ruslan Medzhitov; Charles A Janeway
Journal:  Science       Date:  2002-04-12       Impact factor: 47.728

2.  Regulation of cutaneous malignancy by gammadelta T cells.

Authors:  M Girardi; D E Oppenheim; C R Steele; J M Lewis; E Glusac; R Filler; P Hobby; B Sutton; R E Tigelaar; A C Hayday
Journal:  Science       Date:  2001-09-20       Impact factor: 47.728

3.  The role of the NKG2D immunoreceptor in immune cell activation and natural killing.

Authors:  Amanda M Jamieson; Andreas Diefenbach; Christopher W McMahon; Na Xiong; James R Carlyle; David H Raulet
Journal:  Immunity       Date:  2002-07       Impact factor: 31.745

Review 4.  Natural killer cells, viruses and cancer.

Authors:  A Cerwenka; L L Lanier
Journal:  Nat Rev Immunol       Date:  2001-10       Impact factor: 53.106

5.  Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation.

Authors:  Veronika Groh; Jennifer Wu; Cassian Yee; Thomas Spies
Journal:  Nature       Date:  2002-10-17       Impact factor: 49.962

6.  Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo.

Authors:  A Cerwenka; J L Baron; L L Lanier
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-18       Impact factor: 11.205

7.  Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin.

Authors:  Yoshihiro Hayakawa; Janice M Kelly; Jennifer A Westwood; Phillip K Darcy; Andreas Diefenbach; David Raulet; Mark J Smyth
Journal:  J Immunol       Date:  2002-11-15       Impact factor: 5.422

8.  A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy.

Authors:  Clemens A Schmitt; Jordan S Fridman; Meng Yang; Soyoung Lee; Eugene Baranov; Robert M Hoffman; Scott W Lowe
Journal:  Cell       Date:  2002-05-03       Impact factor: 41.582

9.  c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability.

Authors:  Omid Vafa; Mark Wade; Suzanne Kern; Michelle Beeche; Tej K Pandita; Garret M Hampton; Geoffrey M Wahl
Journal:  Mol Cell       Date:  2002-05       Impact factor: 17.970

10.  Evidence that c-myc mediated apoptosis does not require wild-type p53 during lymphomagenesis.

Authors:  B Hsu; M C Marin; A K el-Naggar; L C Stephens; S Brisbay; T J McDonnell
Journal:  Oncogene       Date:  1995-07-06       Impact factor: 9.867

View more
  36 in total

1.  Methylation of NKG2D ligands contributes to immune system evasion in acute myeloid leukemia.

Authors:  A Baragaño Raneros; V Martín-Palanco; A F Fernandez; R M Rodriguez; M F Fraga; C Lopez-Larrea; B Suarez-Alvarez
Journal:  Genes Immun       Date:  2014-11-13       Impact factor: 2.676

Review 2.  Microenvironment abnormalities and lymphomagenesis: Immunological aspects.

Authors:  Joseph G Taylor; John G Gribben
Journal:  Semin Cancer Biol       Date:  2015-07-29       Impact factor: 15.707

3.  In vivo eradication of MLL/ENL leukemia cells by NK cells in the absence of adaptive immunity.

Authors:  J Nakata; K Nakano; A Okumura; Y Mizutani; H Kinoshita; M Iwai; K Hasegawa; S Morimoto; F Fujiki; N Tatsumi; H Nakajima; Y Nakae; S Nishida; A Tsuboi; Y Oji; Y Oka; H Sugiyama; A Kumanogoh; N Hosen
Journal:  Leukemia       Date:  2013-11-13       Impact factor: 11.528

4.  p38 MAPK differentially controls NK activating ligands at transcriptional and post-transcriptional level on multiple myeloma cells.

Authors:  Alessandra Soriani; Cristiana Borrelli; Biancamaria Ricci; Rosa Molfetta; Alessandra Zingoni; Cinzia Fionda; Silvia Carnevale; Maria Pia Abruzzese; Maria Teresa Petrucci; Maria Rosaria Ricciardi; Giuseppe La Regina; Erica Di Cesare; Patrizia Lavia; Romano Silvestri; Rossella Paolini; Marco Cippitelli; Angela Santoni
Journal:  Oncoimmunology       Date:  2016-12-02       Impact factor: 8.110

5.  Construction of a computable cell proliferation network focused on non-diseased lung cells.

Authors:  Jurjen W Westra; Walter K Schlage; Brian P Frushour; Stephan Gebel; Natalie L Catlett; Wanjiang Han; Sean F Eddy; Arnd Hengstermann; Andrea L Matthews; Carole Mathis; Rosemarie B Lichtner; Carine Poussin; Marja Talikka; Emilija Veljkovic; Aaron A Van Hooser; Benjamin Wong; Michael J Maria; Manuel C Peitsch; Renee Deehan; Julia Hoeng
Journal:  BMC Syst Biol       Date:  2011-07-02

Review 6.  Molecular mechanisms of natural killer cell activation in response to cellular stress.

Authors:  C J Chan; M J Smyth; L Martinet
Journal:  Cell Death Differ       Date:  2013-04-12       Impact factor: 15.828

7.  Distribution of MICB diversity in the Zhejiang Han population: PCR sequence-based typing for exons 2-6 and identification of five novel MICB alleles.

Authors:  Yanling Ying; Yanmin He; Sudan Tao; Zhedong Han; Wei Wang; Nanying Chen; Junjun He; Wei Zhang; Ji He; Faming Zhu; Hangjun Lv
Journal:  Immunogenetics       Date:  2013-04-03       Impact factor: 2.846

Review 8.  Epigenetic Mechanisms Dictating Eradication of Cancer by Natural Killer Cells.

Authors:  Suresh Bugide; Radoslav Janostiak; Narendra Wajapeyee
Journal:  Trends Cancer       Date:  2018-07-03

9.  The proto-oncogene Myc drives expression of the NK cell-activating NKp30 ligand B7-H6 in tumor cells.

Authors:  Sonja Textor; Felicitas Bossler; Kai-Oliver Henrich; Moritz Gartlgruber; Julia Pollmann; Nathalie Fiegler; Annette Arnold; Frank Westermann; Nina Waldburger; Kai Breuhahn; Sven Golfier; Mathias Witzens-Harig; Adelheid Cerwenka
Journal:  Oncoimmunology       Date:  2016-07-28       Impact factor: 8.110

Review 10.  Oncogenic stress sensed by the immune system: role of natural killer cell receptors.

Authors:  David H Raulet; Nadia Guerra
Journal:  Nat Rev Immunol       Date:  2009-08       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.